Multiple Sclerosis

A Current Perspective on Research and Treatment

U.S. FDA approves TG Therapeutics’ multiple sclerosis drug; shares surge

TG Therapeutics Inc. announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved its monoclonal antibody for the treatment of relapsing forms of multiple sclerosis (MS), boosting its shares by 47% in afternoon trading. This approval increases the number of available treatments for the disorder to three, offering a potential financial recovery […]

Continue Reading

Roche warns multiple sclerosis drug development hit by Ukraine war

Roche has raised concerns that Russia’s invasion of Ukraine is hindering the development of new multiple sclerosis (MS) treatments, as the pharmaceutical industry has become increasingly reliant on Eastern Europe for clinical trials. The ongoing conflict has made it challenging for the industry to keep Ukrainian patients enrolled in trials, as millions have fled to […]

Continue Reading

Actress Selma Blair’s struggles with MS depicted in new documentary

In October 2018, Selma Blair shared with her fans that she had been diagnosed with multiple sclerosis, a progressive and incurable neurological disease where the immune system attacks the protective sheath of nerve fibers. Her new documentary, *Introducing, Selma Blair*, follows the actress as she navigates life with the condition and undergoes stem cell treatment. […]

Continue Reading